All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo

Published:2018-09-19 Issue:1 Volume:19 Page:
ISSN:1474-760X
Container-title:Genome Biology
language:en
Short-container-title:Genome Biol

Author:

Ibraheim Raed,Song Chun-Qing,Mir Aamir,Amrani Nadia,Xue Wen,Sontheimer Erik J.^ORCID

Funder

National Institute of General Medical Sciences

National Heart, Lung, and Blood Institute

American Cancer Society

Hyundai Hope On Wheels

Amyotrophic Lateral Sclerosis Association

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13059-018-1515-0.pdf

Reference62 articles.

1. Komor AC, Badran AH, Liu DR. CRISPR-based technologies for the manipulation of eukaryotic genomes. Cell. 2017;168:20–36.

2. Sontheimer EJ, Barrangou R. The bacterial origins of the CRISPR genome-editing revolution. Hum Gene Ther. 2015;26:413–24.

3. Hille F, Richter H, Wong SP, Bratovic M, Ressel S, Charpentier E. The biology of CRISPR-Cas: backward and forward. Cell. 2018;172:1239–59.

4. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337:816–21.

5. Yin H, Kauffman KJ, Anderson DG. Delivery technologies for genome editing. Nat Rev Drug Discov. 2017;16:387–99.

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing CRISPR base editing technology through innovative strategies and ideas;Science China Life Sciences;2024-09-02

2. In vivo dissection of the mouse tyrosine catabolic pathway with CRISPR-Cas9 identifies modifier genes affecting hereditary tyrosinemia type 1;GENETICS;2024-08-23

3. Exploring Advanced CRISPR Delivery Technologies for Therapeutic Genome Editing;Small Science;2024-07-25

4. Next-generation biological vector platforms for in vivo delivery of genome editing agents;Current Opinion in Biotechnology;2024-02

5. Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine;Genes & Diseases;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3